Boehringer Ingelheim (Germany)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes”.
Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel +7 more